UCLA Interventional Radiologist 1st to Perform 'Breakthrough' Procedure

Why It Matters

The breakthrough provides a life‑saving, less invasive treatment for pediatric portal hypertension, expanding options for patients lacking transplant access. Its adoption could reduce mortality and hospitalizations worldwide.

Key Takeaways

• First pediatric percutaneous spleno‑renal shunt performed
• Procedure offers minimally invasive alternative to TIPS
• Could benefit children with portal hypertension worldwide
• Success suggests broader adoption in transplant‑limited cases
• Half of end‑stage liver patients face portal vein thrombosis

Pulse Analysis

Portal hypertension in children, often stemming from portal vein thrombosis after liver disease or transplant, has long been a therapeutic dead‑end. Conventional solutions like TIPS are technically challenging in small patients, while repeat transplantation faces organ scarcity and long waiting lists. This clinical gap has driven interventional radiologists to explore image‑guided, catheter‑based techniques that can restore venous flow without open surgery, a trend reflected in recent adult studies but rarely applied to pediatrics.

In December, Dr. Edward Lee at UCLA leveraged his experience from adult spleno‑renal shunt cases to adapt the procedure for a six‑year‑old with a completely occluded portal vein. Using ultrasound and fluoroscopic guidance, he created a percutaneous conduit between the spleen and renal vein, relieving pressure and halting variceal bleeding. The two‑hour operation, performed under general anesthesia, required custom‑sized catheters and meticulous navigation of the child’s anatomy. Post‑procedure, the boy spent three days in the hospital and has since shown stable liver function and no further bleeding, confirming the technique’s safety and efficacy in a high‑risk pediatric scenario.

The implications extend beyond a single success story. If replicated, percutaneous spleno‑renal shunting could become a standard minimally invasive option for children with portal hypertension, reducing reliance on scarce donor organs and invasive surgeries. Hospitals with advanced interventional radiology suites may adopt the protocol, prompting training programs and multicenter trials to refine patient selection criteria. Moreover, the procedure’s cost‑effectiveness—shorter hospital stays and fewer complications—could appeal to insurers and health systems seeking sustainable solutions for complex liver disease management.